Built inside Lifestyle Rx, truesightᴮᴱᵀᴬ reads a patient’s full treatment history and speaks first, including when it needs to take back something it said.
Dubai, UAE – September 2026: DarDoc, today announced the beta launch of truesightᴮᴱᵀᴬ, a new machine learning powered intelligence layer inside Lifestyle Rx, available to Lifestyle Rx members. It reads everything a patient’s care so far has generated, from the intake form completed before a first consult to yesterday’s dose and step count, and surfaces the one thing worth telling that patient today, before they think to ask.
Most of a patient’s treatment happens between appointments. A patient typically sees a doctor once a month, which means the doctor works from whatever the patient can reconstruct on the spot, and anything the patient forgets or doesn’t think to mention simply doesn’t count. DarDoc built truesightᴮᴱᵀᴬ to close that gap. It draws on consult notes, prescriptions and dose changes, confirmed medication intake, weight, steps and activity data, what the patient has written in their own words in Arabic or English, order and delivery history, and how the patient uses the app itself, including what they ignore.
From that, truesightᴮᴱᵀᴬ keeps a running account of each patient: their stable facts and routines, what they’ve already told the team, what they’ve already declined. Rather than settling early on a single explanation for a change in the data, it holds multiple possibilities open at once, each attached to the evidence that supports it and the evidence that would rule it out. It chooses one thing a day worth surfacing and shows the patient what that judgment is based on. When new information weakens an earlier read, it retracts that observation rather than letting it stand.
Effectively, truesightᴮᴱᵀᴬ functions as an agent with contextual memory of the patient’s full history, present at the appointment itself. It doesn’t hand the doctor a document to skim before they walk in; it carries the thread of the relationship into the room, so the conversation starts from where the patient actually is rather than from a cold open. The physician isn’t reconstructing the month from a chart. They already know what’s changed, what’s been tried, what’s been declined and why, before the patient sits down. One step ahead, by design.
“Healthcare has traditionally focused on the treatment itself, but outcomes are shaped by what happens between appointments. That’s where adherence and persistence matter most,” said Keswin cofounder, DarDoc.
“We built truesightᴮᴱᵀᴬ to be the companion layer that carries each patient’s context forward and helps them stay on track toward the outcome they came to us for.”
By design, truesightᴮᴱᵀᴬ does not diagnose, prescribe or treat. It organises information the patient has already provided and presents it to the patient and their care team, so clinical decisions remain with licensed clinicians. Before a consult, it hands the doctor a structured summary of the month, so the appointment starts from context rather than reconstruction.
The product is deliberately quiet by design. It surfaces one small prompt at a time, usually resolved with a single tap, and says nothing on days when there is nothing worth saying. When a patient shares context, such as travel, hospitalisation or fasting during Ramadan, it adjusts accordingly rather than flagging normal life as a missed target.
In one example from the beta, a patient’s weight and meal pattern shifted over a week. Rather than guessing at a cause, truesightᴮᴱᵀᴬ asked directly whether anything had changed. The patient explained they were staying at a hospital with a family member. The system did not log the week as non-adherence, and the patient’s doctor saw the context rather than a gap in the data.
“We built this because the real treatment doesn’t happen in the appointment, it happens in the weeks around it – that’s what truesightᴮᴱᵀᴬ carries forward, so nothing gets lost between visits,” said Keswin, cofounder, DarDoc.
A second phase is set to follow shortly after beta.
In its second phase, truesightᴮᴱᵀᴬ will extend into the consult itself as a note-taking scribe, transcribing the physician-patient conversation in real time so nothing said in the room gets lost. Transcription will be always-on: patients consent during Lifestyle Rx onboarding, and all DarDoc physicians, who are employed directly by DarDoc, operate under a standing agreement to use the tool. The same system now draws on lab tests, so what gets said in the room sits alongside the patient’s digitized biomarker history rather than apart from it, giving truesightᴮᴱᵀᴬ a fuller picture built from both the conversation and the data behind it.
DarDoc believes truesightᴮᴱᵀᴬ is the first system of its kind in the UAE.
The tool is live now in beta for Lifestyle Rx members. The beta is available first to iOS users, with Android availability to follow after the iOS release. The company is not disclosing beta enrolment numbers. TrueSight is not connected to DarDoc’s separate partnership with Novo Nordisk.
DarDoc is an alumnus of the Mohammed Bin Rashid Innovation Fund (MBRIF) Innovation Accelerator programme, an initiative of the UAE Ministry of Finance, where it received tailored mentorship, strategic guidance and access to the wider innovation ecosystem as it developed and scaled its business.
